Some of these responses are altered in breast cancer cells expressing different BRCA1 mutations, in line with previous predictions that mutated forms of BRCA1 will determine tumor cell sensitivity or resistance to different types of chemo- or radiotherapies [7]. The gene discussed is BRCA1; the disease is breast carcinoma.